Rankings
▼
Calendar
KLRS Q1 2022 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena
KLRS
Kalaris Therapeutics Inc
$187M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$846,000
Operating Income
-$43M
Net Income
-$44M
EPS (Diluted)
$-15.76
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$46M
Free Cash Flow
-$46M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$231M
Total Liabilities
$39M
Stockholders' Equity
$192M
Cash & Equivalents
$100M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$846,000
-$18,000
-4600.0%
Operating Income
-$43M
-$31M
-40.0%
Net Income
-$44M
-$31M
-41.8%
← FY 2022
All Quarters
Q2 2022 →